Targeting VEGF in lung cancer

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.16, Iss.4, 2012-04, pp. : 395-406

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Tumorangiogenesis in Lung Cancer by Suppression of VEGF and its Receptor - Results from Clinical Trials and Novel Experimental Approaches

Current Medicinal Chemistry, Vol. 14, Iss. 30, 2007-12 ,pp. : 3157-3165

Bentham Science Publishers

Access to resources Recommend Favorite

Dilemma in metastatic colorectal cancer: VEGF versus EGRF targeting

By Rolfo Christian

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 8, 2013-08 ,pp. : 869-871

Informa Healthcare

Access to resources Recommend Favorite

Targeting signaling pathways in lung cancer therapy

By Cho William CS

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 2, 2013-02 ,pp. : 107-111

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic targeting of receptor tyrosine kinases in lung cancer

By Choong Nicholas W Ma Patrick C Salgia Ravi

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 3, 2005-06 ,pp. : 533-559

Informa Healthcare

Access to resources Recommend Favorite

Targeting Apoptotic Signaling Pathways in Human Lung Cancer

Current Cancer Drug Targets, Vol. 10, Iss. 6, 2010-09 ,pp. : 566-574

Bentham Science Publishers

Access to resources Recommend Favorite